Business Context and Reporting Period
This Form 8-K was filed by Grubb & Ellis Healthcare REIT, Inc. (the "Company") on May 21, 2009. The filing reports a material definitive agreement and the termination of a prior agreement regarding the Company's Initial Public Offering (IPO). The Company is currently transitioning from an externally managed structure to self-management and intends to change its name to Healthcare Trust of America, Inc.
Key Financial Metrics and Agreements
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or debt levels. Instead, it details the financial terms of a new Dealer Manager Agreement with Realty Capital Securities, LLC ("RCS"), effective August 29, 2009:
- Selling Commission: 7.0% of gross offering proceeds from primary offering sales (subject to volume reductions).
- Marketing Support Fee: 2.5% of gross offering proceeds.
- Due Diligence Reimbursement: Up to 0.5% of gross offering proceeds for bona fide expenses.
- Reallowance: RCS may reallow up to 1.5% of the marketing support fee and the full selling commission to Participating Broker-Dealers.
- Commitment: RCS has no firm commitment or obligation to purchase shares.
Material Changes
The primary material change is the replacement of the dealer manager for the Company's IPO:
- Termination: Grubb & Ellis Securities, Inc. ("GES") will cease serving as dealer manager on August 28, 2009.
- Succession: Realty Capital Securities, LLC ("RCS") will assume the role of dealer manager commencing August 29, 2009, subject to regulatory approvals.
- Scope: The new agreement covers the remainder of the current IPO and a proposed follow-on offering (File No. 333-158418), which is not yet effective.
Outlook, Risks, and Management Commentary
Management Strategy: The dealer manager transition is directly related to the Company's strategic shift to self-management. The Company plans to rename itself Healthcare Trust of America, Inc. concurrently with this transition.
Risks and Contingencies:
- Regulatory Approval: The effectiveness of the RCS agreement is contingent upon receiving a letter from the Financial Industry Regulatory Authority ("FINRA") stating no objections to the underwriting terms.
- Liability: The Company has agreed to indemnify RCS and Participating Broker-Dealers against liabilities arising from breaches of the agreement or material misstatements in the prospectus or sales materials.
- Offering Status: No sales have been made in the proposed follow-on offering as the registration statement is not yet effective.
Investor Verification Checklist
- Verify the receipt of FINRA approval for the RCS Dealer Manager Agreement.
- Confirm the timeline for the Company's name change to Healthcare Trust of America, Inc.
- Monitor the status of the proposed follow-on offering (File No. 333-158418) to determine if it becomes effective.
- Review the full text of the RCS Dealer Manager Agreement (Exhibit 1.1) for specific termination clauses and indemnity limits.
- Assess the impact of the 10% total fee structure (7.0% commission + 2.5% marketing + 0.5% reimbursement) on net proceeds from the IPO.